Vacancy expired!
About This Role:The Area Business Manager’s main responsibilities are to maximize the success sales and profits of Biogen’ biosimilar products by developing and executing strategic account plans at the local level, in alignment with Biogen’s Code of Conduct, compliance and regulatory standards.What You’ll Do:Responsibilities:Utilize resources internally to analyze territory and/or marketplace performance, identifying customer needs, defining, and executing effective action plans, implementing local marketing strategies; organizing and activating face to face and virtual customer meetings with Health Care Professional (HCPs) and Account Staff that drive business opportunities.Develop and execute an effective territory business plan to further strengthen and maximize territory sales and profits.Build and strengthen business opportunities through successful targeting and segmentation of HCPs and Account Staff, working in collaboration with Strategic Account Executives to ensure optimal HCP/Account alignment.Drive business needs and US Biogen biosimilars utilization in assigned accounts, ensuring academic center/institutional formulary inclusion.Partner with and work collaboratively/compliantly with all applicable teams across the US Biosimilar Business Unit including Strategic Accounts, Marketing, Market Access & Reimbursement, Patient Services and Medical, to support territory activities through expert engagement and support.Ensure that US Biosimilars Business Unit market share is maximized within new and existing Accounts.Ensure all interactions and activities, both internal and external are in-line with all compliance regulations and territory budgets.Who You Are:As part of the US Biosimilars Business Unit (BBU) commercial team, you will be part of a global business unit. You will be part of a team of people who are empowered to work with autonomy, agility, and determination to deliver for patients.   US BBU presents a unique opportunity for committed experienced professionals who are ready to unlock the potential of biosimilars to transform more lives.
